[1] |
Chaturvedi S.Diagnosis and management of large artery atherosclerosis[J]. Continuum (Minneap Minn),2023,29(2):486-500. DOI:10.1212/con.0000000000001212.
|
[2] |
李旺俊,王云霞.抽吸联合支架取栓对超时间窗后循环缺血性脑卒中患者脑血灌注的影响[J].中华脑科疾病与康复杂志(电子版),2023,13(6):352-357.DOI:10.3877/cma.j.issn.2095-123X.2023.06.006.Li WJ,Wang YX. Effects of aspiration combine stent for thrombectomy on cerebral blood perfusion in patients with posterior circulation ischemic stroke beyond the time window[J].Chin J Brain Dis Rehabil (Electronic Edition),2023,13(6):352-357.DOI:10.3877/cma.j.issn.2095-123X.2023.06.006.
|
[3] |
Kim TJ,Lee JS,Yoon JS,et al. Optimal use of antithrombotic agents in ischemic stroke with atrial fibrillation and large artery atherosclerosis[J]. Int J Stroke,2023,18(7):812-820. DOI:10.1177/17474930231158211.
|
[4] |
Yu Y,Zhang FL,Qu YM,et al. Intracranial calcification is predictive for hemorrhagic transformation and prognosis after intravenous thrombolysis in non-cardioembolic stroke patients[J].J Atheroscler Thromb,2021,28(4):356-364. DOI:10.5551/jat.55889.
|
[5] |
Spronk E,Sykes G,Falcione S,et al. Hemorrhagic transformation in ischemic stroke and the role of inflammation[J]. Front Neurol,2021,12:661955.DOI:10.3389/fneur.2021.661955.
|
[6] |
Figueroa EG,González-Candia A,Caballero-Román A,et al.Blood-brain barrier dysfunction in hemorrhagic transformation:a therapeutic opportunity for nanoparticles and melatonin[J]. J Neurophysiol,2021,125(6):2025-2033. DOI:10.1152/jn.00638.2020.
|
[7] |
刘杨辉,李天晓,朱良付,等.ASL 评估脑梗死灶血脑屏障通透性及预测血管开通后出血转化的价值[J].中华神经医学杂志,2022,21(9):870-878. DOI:10.3760/cma.j.cn115354-20220516-00343.Liu YH,Li TX,Zhu LF,et al. Values of arterial spin labeling in evaluating blood-brain barrier permeability in cerebral infarction lesions and predicting hemorrhage transformation after endovascular recanalization[J].Chin J Neuromed,2022,21(9):870-878.DOI:10.3760/cma.j.cn115354-20220516-00343.
|
[8] |
Zhu H,Jian Z,Zhong Y,et al.Janus kinase inhibition ameliorates ischemic stroke injury and neuroinflammation through reducing NLRP3 inflammasome activation via JAK2/STAT3 pathway inhibition[J]. Front Immunol,2021,12:714943. DOI:10.3389/fimmu.2021.714943.
|
[9] |
Chen H,Guan B,Chen S,et al. Peroxynitrite activates NLRP3 inflammasome and contributes to hemorrhagic transformation and poor outcome in ischemic stroke with hyperglycemia[J]. Free Radic Biol Med,2021,165:171-183.DOI:10.1016/j.freeradbiomed.2021.01.030.
|
[10] |
Cheng X,Ren Z,Jia H,et al. METTL3 mediates microglial activation and blood - brain barrier permeability in cerebral ischemic stroke by regulating NLRP3 inflammasomes through m6A methylation modification[J]. Neurotox Res,2024,42(1):15.DOI:10.1007/s12640-024-00687-2.
|
[11] |
中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组.中国急性缺血性脑卒中诊治指南2018[J].中华神经科杂志,2018,51(9):666-682.DOI:10.3760/cma.j.issn.1006-7876.2018.09.004.Chinese Society of Neurology; Chinese Stroke Society. Chinese guidlines for diagnosis and treatment of acute ischemic stroke 2018[J]. Chin J Neurol,2018,51(9):666-682. DOI:10.3760/cma.j.issn.1006-7876.2018.09.004.
|
[12] |
张磊,刘建民.美国国立卫生研究院卒中量表[J].中华神经外科杂志,2014,30(1):79.Zhang L,Liu JM. National Institutes of Health stroke scale[J].Chin J Neurosurg,2014,30(1):79.
|
[13] |
杨远芳,滕跃华,邵帅.高信号血管征与大脑中动脉狭窄程度和脑梗死面积的关系研究[J].影像科学与光化学,2022,40(6):1524-1528.DOI:10.7517/issn.1674-0475.220721.Yang YF,Teng YH,Shao S. Study on the relationship between hyperintense vessel sign and the degree of middle cerebral artery stenosis and cerebral infarction area[J]. Imaging Science and Photochemistry,2022,40(6):1524-1528. DOI:10.7517/issn.1674-0475.220721.
|
[14] |
中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组.中国急性脑梗死后出血转化诊治共识2019[J].中华神经科杂志,2019,52(4):252-265. DOI:10.3760/cma.j.issn.1006-7876.2019.04.003.Chinese Society of Neurology; Chinese Stroke Society. Consensus on diagnosis and treatment of hemorrhagic transformation after acute ischemic stroke in China 2019[J]. Chin J Neurol,2019,52(4):252-265.DOI:10.3760/cma.j.issn.1006-7876.2019.04.003.
|
[15] |
Larrue V,von Kummer RR,Müller A,et al. Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator:a secondary analysis of the European-Australasian Acute Stroke Study(ECASS Ⅱ)[J].Stroke,2001,32(2):438-441.DOI:10.1161/01.str.32.2.438.
|
[16] |
Haggag H,Hodgson C.Clinimetrics:modified Rankin scale(mRS)[J]. J Physiother,2022,68(4):281. DOI:10.1016/j.jphys.2022.05.017.
|
[17] |
王玉兰,魏淑琦,吕敬雷,等.大动脉粥样硬化型脑梗死患者脑微出血与脑动脉狭窄的相关性[J]. 中风与神经疾病杂志,2022,39(4):317-323.DOI:10.19845/j.cnki.zfysjjbzz.2022.0081.Wang YL,Wei SQ,Lyu JL,et al. The relationship between cerebral microbleeds and cerebral artery stenosis in patients with large atherosclerotic cerebral infarction[J]. J Apoplexy Nerv Dis,2022,39(4):317-323.DOI:10.19845/j.cnki.zfysjjbzz.2022.0081.
|
[18] |
李刚,潘晓帆,田雪,等.CT 灌注成像参数及血栓弹力图对急性前循环脑梗死早期神经功能恶化的预测价值分析[J].中华神经创伤外科电子杂志,2024,10(4):226-232. DOI:10.3877/cma.j.issn.2095-9141.2024.04.006.Li G,Pan XF,Tian X,et al. Predictive value of CT perfusion imaging parameters and thromboelogram for early neurological deterioration of acute anterior circulatory cerebral infarction[J].Chin J Neurotrauma Surg (Electronic Edition),2024,10(4):226-232.DOI:10.3877/cma.j.issn.2095-9141.2024.04.006.
|
[19] |
Bani-Sadr A,Mechtouff L,De Bourguignon C,et al. Blood-brain barrier permeability and kinetics of inflammatory markers in acute stroke patients treated with thrombectomy[J]. Neurology,2023,101(5):e502-e511.DOI:10.1212/wnl.0000000000207460.
|
[20] |
Arba F,Rinaldi C,Caimano D,et al. Blood - brain barrier disruption and hemorrhagic transformation in acute ischemic stroke:systematic review and meta - analysis[J]. Front Neurol,2020,11:594613.DOI:10.3389/fneur.2020.594613.
|
[21] |
Fu J,Wu H. Structural mechanisms of NLRP3 inflammasome assembly and activation[J]. Annu Rev Immunol,2023,41:301-316.DOI:10.1146/annurev-immunol-081022-021207.
|
[22] |
Zeng X,Liu D,Huo X,et al.Pyroptosis in NLRP3 inflammasomerelated atherosclerosis[J]. Cell Stress,2022,6(10):79-88. DOI:10.15698/cst2022.10.272.
|
[23] |
Liu P,Wang Y,Tian K,et al.Artesunate inhibits macrophage-like phenotype switching of vascular smooth muscle cells and attenuates vascular inflammatory injury in atherosclerosis via NLRP3[J].Biomed Pharmacother,2024,172:116255.DOI:10.1016/j.biopha.2024.116255.
|
[24] |
Shao A,Gao S,Wu H,et al. Melatonin ameliorates hemorrhagic transformation via suppression of ROS-induced NLRP3 activation after cerebral ischemia in hyperglycemic rats[J]. Oxid Med Cell Longev,2021,2021:6659282.DOI:10.1155/2021/6659282.
|
[25] |
Xu Y,Fang X,Zhao Z,et al. GPR124 induces NLRP3 inflammasome-mediated pyroptosis in endothelial cells during ischemic injury[J].Eur J Pharmacol,2024,962:176228.DOI:10.1016/j.ejphar.2023.176228.
|
[26] |
Bellut M,Papp L,Bieber M,et al. NLRP3 inflammasome inhibition alleviates hypoxic endothelial cell death in vitro and protects blood-brain barrier integrity in murine stroke[J]. Cell Death Dis,2021,13(1):20.DOI:10.1038/s41419-021-04379-z.
|
[27] |
Zheng Y,Zhu T,Chen B,et al. Diallyl disulfide attenuates pyroptosis via NLRP3/Caspase-1/IL-1β signaling pathway to exert a protective effect on hypoxic-ischemic brain damage in neonatal rats[J]. Int Immunopharmacol,2023,124(Pt B):111030. DOI:10.1016/j.intimp.2023.111030.
|